A
Arbutus Biopharma (ABUS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Arbutus Biopharma (ABUS)
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing cure for people with chronic hepatitis B virus (HBV) infection. Its product pipeline is focused on find... Read more
- USD2.64
- USD2.75
- USD2.64
- USD3.29
- 5.60%
- 24M
- 1.09M
- 2.29M
- 490M
- 1.69
- -12.00%
Stock News
yesterday
Broadway Financial Corporation Discloses Receipt of Notice From Nasdaq Regarding Filing Requirement for the Company’s Form 10-K
Yahoo
yesterday
Texas Instruments Stock Jumps as Earnings Edge Estimates
Yahoo
yesterday
Texas Instruments Gives Solid Forecast in Sign of Comeback
Yahoo
yesterday
Chipmaker Texas Instruments Beats Q1 Goals, Gives Reassuring Outlook
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
